1. Home
  2. CMAX vs CVKD Comparison

CMAX vs CVKD Comparison

Compare CMAX & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMAX
  • CVKD
  • Stock Information
  • Founded
  • CMAX 2011
  • CVKD 2022
  • Country
  • CMAX United States
  • CVKD United States
  • Employees
  • CMAX N/A
  • CVKD N/A
  • Industry
  • CMAX Computer Software: Prepackaged Software
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • CMAX Technology
  • CVKD Health Care
  • Exchange
  • CMAX Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • CMAX 8.3M
  • CVKD 8.2M
  • IPO Year
  • CMAX N/A
  • CVKD 2023
  • Fundamental
  • Price
  • CMAX $3.89
  • CVKD $0.45
  • Analyst Decision
  • CMAX Hold
  • CVKD Strong Buy
  • Analyst Count
  • CMAX 2
  • CVKD 2
  • Target Price
  • CMAX $33.20
  • CVKD $3.50
  • AVG Volume (30 Days)
  • CMAX 6.5M
  • CVKD 72.2K
  • Earning Date
  • CMAX 08-07-2024
  • CVKD 08-12-2024
  • Dividend Yield
  • CMAX N/A
  • CVKD N/A
  • EPS Growth
  • CMAX N/A
  • CVKD N/A
  • EPS
  • CMAX N/A
  • CVKD N/A
  • Revenue
  • CMAX $810,364,000.00
  • CVKD N/A
  • Revenue This Year
  • CMAX $21.67
  • CVKD N/A
  • Revenue Next Year
  • CMAX $1.21
  • CVKD N/A
  • P/E Ratio
  • CMAX N/A
  • CVKD N/A
  • Revenue Growth
  • CMAX 21.46
  • CVKD N/A
  • 52 Week Low
  • CMAX $1.55
  • CVKD $0.36
  • 52 Week High
  • CMAX $85.80
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • CMAX 59.41
  • CVKD 48.55
  • Support Level
  • CMAX $1.55
  • CVKD $0.43
  • Resistance Level
  • CMAX $6.64
  • CVKD $0.49
  • Average True Range (ATR)
  • CMAX 0.76
  • CVKD 0.02
  • MACD
  • CMAX 0.23
  • CVKD -0.00
  • Stochastic Oscillator
  • CMAX 45.97
  • CVKD 39.47

About CMAX CareMax Inc.

CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: